YU50701A - 2,3-o-izopropiliden derivati monosaharida kao inhibitori ćelijske adhezije - Google Patents
2,3-o-izopropiliden derivati monosaharida kao inhibitori ćelijske adhezijeInfo
- Publication number
- YU50701A YU50701A YU50701A YUP50701A YU50701A YU 50701 A YU50701 A YU 50701A YU 50701 A YU50701 A YU 50701A YU P50701 A YUP50701 A YU P50701A YU 50701 A YU50701 A YU 50701A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- cell adhesion
- derivatives
- izopropylidene
- monosaccharides
- adhesion inhibitors
- Prior art date
Links
- 230000021164 cell adhesion Effects 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 150000002772 monosaccharides Chemical class 0.000 title 1
- 239000002253 acid Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000007170 pathology Effects 0.000 abstract 2
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 230000017455 cell-cell adhesion Effects 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 239000008196 pharmacological composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 230000002194 synthesizing effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
- C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
- C07H9/04—Cyclic acetals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Transplantation (AREA)
- Surgery (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN86DE1999 IN190975B (cg-RX-API-DMAC7.html) | 1999-01-15 | 1999-01-15 | |
| US09/276,368 US6590085B1 (en) | 1999-01-15 | 1999-03-25 | Derivatives of monosaccharides as cell adhesion inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU50701A true YU50701A (sh) | 2005-06-10 |
Family
ID=11088155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU50701A YU50701A (sh) | 1999-01-15 | 2000-01-10 | 2,3-o-izopropiliden derivati monosaharida kao inhibitori ćelijske adhezije |
Country Status (30)
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN190975B (cg-RX-API-DMAC7.html) * | 1999-01-15 | 2003-09-06 | Ranbaxy Lab Ltd | |
| NZ577031A (en) | 2003-05-30 | 2010-09-30 | Ranbaxy Lab Ltd | Substituted pyrrole derivatives and their use as HMG-CO inhibitors |
| WO2006024926A1 (en) * | 2004-09-02 | 2006-03-09 | Ranbaxy Laboratories Limited | Monosaccharide derivatives |
| WO2007063356A2 (en) * | 2004-12-22 | 2007-06-07 | Ranbaxy Laboratories Limited | Derivatives of pentose monosaccharides as anti-inflammatory compounds |
| US20090054519A1 (en) * | 2005-07-22 | 2009-02-26 | Abhijit Ray | Derivatives of monosaccharides as 5-lipoxygenase inhibitors |
| BRPI0618379A2 (pt) * | 2005-11-08 | 2011-08-30 | Ranbaxy Lab Ltd | processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico |
| CL2007000667A1 (es) * | 2006-03-14 | 2008-03-14 | Ranbaxi Lab Ltd | Composicion farmaceutica que comprende al acido 7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroximetilfenilamino)carbonil]pirrol-1-il]-3,5-dihidroxi-heptanoico o una sal y al menos un agente estabilizante; procedimiento de preparacion, util en e |
| US20080114031A1 (en) * | 2006-03-29 | 2008-05-15 | Sattigeri Viswajanani J | Monosaccharide derivatives |
| EP1864992A2 (en) * | 2006-05-30 | 2007-12-12 | Ranbaxy Laboratories, Ltd. | Monosaccharide derivatives |
| EP1953170A1 (en) * | 2006-10-03 | 2008-08-06 | Ranbaxy Laboratories Limited | Monosaccharide derivatives as anti-inflammatory agents |
| AU2008221506B2 (en) * | 2007-09-20 | 2011-01-20 | ResMed Pty Ltd | Retractable Tube for CPAP |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2715121A (en) | 1950-09-09 | 1955-08-09 | American Home Prod | Alkyl sugar derivatives and their preparation |
| US4056322A (en) | 1973-12-14 | 1977-11-01 | Strategic Medical Research Corporation | Preparation of ethers of monosaccharides |
| US4735934A (en) | 1981-02-17 | 1988-04-05 | Greenwich Pharmaceuticals Incorporated | Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease |
| US4996195A (en) * | 1989-01-09 | 1991-02-26 | Greenwich Pharmaceuticals Inc. | Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives |
| US5010058A (en) * | 1989-06-22 | 1991-04-23 | 501 Greenwich Pharmaceuticals Incorporated | 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives |
| FR2652540B1 (fr) | 1989-10-02 | 1995-06-02 | Imaje Sa | Circuit d'encre notamment destine a la mise en pression d'une encre a pigments pour imprimante a jet d'encre. |
| US5192746A (en) | 1990-07-09 | 1993-03-09 | Tanabe Seiyaku Co., Ltd. | Cyclic cell adhesion modulation compounds |
| US5258402A (en) | 1992-06-11 | 1993-11-02 | Mcneil-Ppc, Inc. | Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates |
| US5432163A (en) | 1992-11-13 | 1995-07-11 | Greenwich Pharmaceuticals Incorporated | Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides |
| US5637570A (en) * | 1995-05-09 | 1997-06-10 | Chemora Pharmochem | Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity |
| IN190975B (cg-RX-API-DMAC7.html) * | 1999-01-15 | 2003-09-06 | Ranbaxy Lab Ltd |
-
1999
- 1999-01-15 IN IN86DE1999 patent/IN190975B/en unknown
- 1999-03-25 US US09/276,368 patent/US6590085B1/en not_active Expired - Fee Related
-
2000
- 2000-01-10 SK SK10132001A patent/SK284241B6/sk unknown
- 2000-01-10 CA CA002359986A patent/CA2359986A1/en not_active Abandoned
- 2000-01-10 AR ARP000100086A patent/AR022235A1/es not_active Application Discontinuation
- 2000-01-10 DK DK00900088T patent/DK1147119T3/da active
- 2000-01-10 HU HU0105116A patent/HUP0105116A3/hu unknown
- 2000-01-10 HR HR20010529A patent/HRP20010529B1/xx not_active IP Right Cessation
- 2000-01-10 MX MXPA01007187A patent/MXPA01007187A/es not_active IP Right Cessation
- 2000-01-10 YU YU50701A patent/YU50701A/sh unknown
- 2000-01-10 NZ NZ512852A patent/NZ512852A/xx unknown
- 2000-01-10 CZ CZ20012540A patent/CZ20012540A3/cs unknown
- 2000-01-10 CN CNB008048525A patent/CN1167707C/zh not_active Expired - Fee Related
- 2000-01-10 ID IDW00200101520A patent/ID30351A/id unknown
- 2000-01-10 AT AT00900088T patent/ATE250074T1/de not_active IP Right Cessation
- 2000-01-10 TR TR2001/02043T patent/TR200102043T2/xx unknown
- 2000-01-10 PT PT00900088T patent/PT1147119E/pt unknown
- 2000-01-10 EP EP00900088A patent/EP1147119B1/en not_active Expired - Lifetime
- 2000-01-10 ES ES00900088T patent/ES2206176T3/es not_active Expired - Lifetime
- 2000-01-10 NZ NZ527483A patent/NZ527483A/en unknown
- 2000-01-10 DE DE60005300T patent/DE60005300T2/de not_active Expired - Fee Related
- 2000-01-10 AU AU18861/00A patent/AU768511B2/en not_active Ceased
- 2000-01-10 WO PCT/IB2000/000022 patent/WO2000042054A1/en not_active Ceased
- 2000-01-10 BR BR0007553-1A patent/BR0007553A/pt not_active IP Right Cessation
- 2000-01-10 JP JP2000593621A patent/JP2002534530A/ja active Pending
- 2000-01-14 MY MYPI20000121A patent/MY121135A/en unknown
- 2000-01-14 PA PA20008489901A patent/PA8489901A1/es unknown
- 2000-01-14 CO CO00001575A patent/CO5180591A1/es not_active Application Discontinuation
-
2001
- 2001-07-12 CR CR6423A patent/CR6423A/xx not_active Application Discontinuation
- 2001-07-12 MA MA26266A patent/MA25342A1/fr unknown
- 2001-07-26 BG BG105745A patent/BG105745A/xx unknown
-
2003
- 2003-07-01 US US10/611,093 patent/US7005422B2/en not_active Expired - Fee Related
- 2003-07-01 US US10/611,386 patent/US7005516B2/en not_active Expired - Fee Related
- 2003-07-01 US US10/610,719 patent/US7037899B2/en not_active Expired - Fee Related
- 2003-07-01 US US10/611,091 patent/US20040018995A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU50701A (sh) | 2,3-o-izopropiliden derivati monosaharida kao inhibitori ćelijske adhezije | |
| AU6328286A (en) | Intermediates for the production of amino and substituted amino phosphinylalkanoyl compositions | |
| CA2362003A1 (en) | Heterocyclic urea and related compounds useful as anti-inflammatory agents | |
| EP1017382A4 (en) | BIARYL ALKANIC ACIDS USED AS CELL ADHESION INHIBITORS | |
| WO2000008048A3 (en) | Inhibitor of histone deacetylase | |
| WO2002046171A3 (en) | Anilinopyrimidine derivatives as ikk inhibitors and compositions and methods related thereto | |
| TNSN06074A1 (en) | Pyrimidine derivatives for the treatment of abnormal cell growth | |
| CA2244785A1 (en) | Pentafluorobenzenesulfonamides and analogs | |
| TNSN04141A1 (en) | NEW COMPOUNDS - DDP - IV difluor | |
| AU1617901A (en) | Urea derivatives as anti-inflammatory agents | |
| IL163629A0 (en) | Glutaminyl derivatives and pharmaceutical compositions containing the same | |
| WO2005092895A3 (en) | Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as orl1-receptor antagonists | |
| WO2004011403A3 (en) | Alkali metal hydrogen phosphates as precursors for phosphate-containning electrochemical active materials | |
| HK1045146A1 (zh) | 抑制细胞黏附抗炎症和免疫抑制化合物 | |
| JPS56128767A (en) | Substituted imidazole derivative, its manufacture and medicine as effective component | |
| IL143625A0 (en) | Sulfonamide hydroxamates | |
| NO986049L (no) | Matrise metallproteinaseinhibitorer | |
| DE69832995D1 (de) | Betainprodukt,verfahren zu seiner herstellung und seiner verwendung | |
| BG100926A (en) | Method for the preparation of purines | |
| IL181267A0 (en) | Vla-4 antagonists | |
| IL124431A0 (en) | Sulfur containing dl-tert-butylphenol compounds useful as anti-inflammatory agents | |
| JO2237B1 (en) | Derivatives of the mono glycemic compound are used as cellular adhesion inhibitors | |
| WO2003080631A8 (en) | Plasma carboxypeptidase b inhibitors | |
| WO2006016237A3 (en) | Heterocyclic derivatives as anti-inflammatory agents | |
| DE60332931D1 (en) | Hydroxamsäurederivate |